<![CDATA[LFB 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=34880>Thu, 14 May 2026 04:16:00 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[LFB, 억제체 동반한 성인 및 청소년 A형 또는 B형 혈우병 환자 치료 위한 새 재조합 응고인자 VIIa인 ‘세븐팩트’를 FDA가 승인했다고 발표]]>https://www.newswire.co.kr/newsRead.php?no=903465Tue, 07 Apr 2020 16:35:23 +0900<![CDATA[LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors]]>https://www.newswire.co.kr/newsRead.php?no=903464Tue, 07 Apr 2020 16:18:14 +0900